Insider Trading23 Sept 2026, 02:29 pm
Lincoln Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Lincoln Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 01, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ended September 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015. All directors, senior management, promoters, and connected persons are advised not to trade during this period. The date for the Board of Directors' meeting to approve these financial results will be communicated separately.
Key Highlights
- Trading window closed from October 01, 2026.
- Closure is for Q2 FY27 financial results announcement.
- Restrictions apply to directors, management, and promoters.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting date for results approval to be announced later.
Price Impact
More from LINCOLN